oestradiol
elanco australasia pty ltd - oestradiol - unknown - oestradiol steroid-estrogen active 0.0 - active constituent
oestradiol cypionate
syntex s.a. - oestradiol cypionate - unknown - oestradiol cypionate steroid-estrogen active 0.0 - active constituent
elevet+ oestradiol benzoate injection
avet health limited - oestradiol benzoate - parenteral liquid/solution/suspension - oestradiol benzoate steroid-estrogen active 1.0 mg/ml - endocrine system
zoely
merck sharp & dohme australia pty ltd - oestradiol hemihydrate; nomegestrol acetate -
angeliq 1/2
bayer australia ltd - drospirenone; oestradiol hemihydrate; oestradiol -
angeliq
bayer israel ltd - drospirenone; estradiol as hemihydrate - film coated tablets - drospirenone 2 mg; estradiol as hemihydrate 1 mg - estradiol - estradiol - angeliq is indicated for hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women more than 1 year post menopause. prevention of postmenopausal osteoporosis in women with an increased risk of future osteoporosis fractures.
synovex c calf growth promotant
zoetis australia pty ltd - oestradiol benzoate; progesterone; detectable marker - parenteral implant, device - oestradiol benzoate steroid-estrogen active 10.0 mg/im; progesterone steroid-progestin active 100.0 mg/im; detectable marker miscellaneous other 0.0 p - nutrition & metabolism - calf | beef calf | bovine | calf - poddy | calf - preweaning | calf - sucker | dairy calf | neonatal calf - promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain
invokana canagliflozin (as hemihydrate)100 mg film-coated tablet blister pack
janssen-cilag pty ltd - canagliflozin hemihydrate -
invokana canagliflozin (as hemihydrate) 300 mg film-coated tablet blister pack
janssen-cilag pty ltd - canagliflozin hemihydrate -
bijuva 1/100 estradiol (as hemihydrate) 1 mg progesterone 100 mg capsule blister pack
theramex australia pty ltd - estradiol hemihydrate, quantity: 1 mg; progesterone, quantity: 100 mg - capsule, soft - excipient ingredients: mono- and di- glycerides; gelatin; glycerol; purified water; lauroyl macrogolglycerides; hydrolysed gelatin; allura red ac; titanium dioxide; propylene glycol; ethyl acetate; ethanol; isopropyl alcohol; strong ammonia solution; polyvinyl acetate phthalate; macrogol 400 - bijuva 1/100 is indicated for use during continuous combined hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women with an intact uterus and with at least 12 months since last menses.